Research Article
Orthotopic Liver Transplantation in Human-Immunodeficiency-Virus-Positive Patients in Germany
Table 4
Recurrence and prevention of hepatitis B in HIV-positive patients after OLT.
| | Viral hepatitis | HBV therapy | HBV virus |
| | HBV | 3TC, HBs-Ig | HBsAg negative | | HBV | 3TC, HBs-Ig | HBsAg negative | | HBV | 3TC, HBs-Ig | HBsAg negative | | HBV | TDF, HBs-Ig | HBsAg negative | | HBV | TDF, HBs-Ig | HBsAg negative | | HBV | 3TC | HBsAg negative | | HBV/HCV/HDV | 3TC | HBsAg negative | | HBV | 3TC, entecavir | HBsAg negative | | HBV | TDF, 3TC | low viremia | | HBV | TDF | HBsAg negative | | HBV/HCV | TDF, HBs-Ig | HBsAg negative | | HBV | 3TC | HBsAg negative |
|
|
3TC: lamivudine, TDF: tenofovir, HBs-Ig: HBs hyperimmunoglobulin, HCV: hepatitis C virus, HBV: hepatitis B virus, HDV: hepatitis D virus.
|
